Summary
Further key aspects of the report:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Nano-drug market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Nano-drug market segmented into
Liposomes
Polymeric Micelles
Solid lipid Nanoparticles
Microemulsion and Nanoemulsion
Nanosuspension
Based on the end-use, the global Nano-drug market classified into
Cancer and Tumors
Autoimmune Disorders
Based on geography, the global Nano-drug market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
Merck
Pfizer
Novartis
Abbott
GlaxoSmithKline
Roche
Sanofi
Eli Lilly
Astrazeneca
Johnson & Johnson
Celgene
Novavax
Stryker
Gilead Sciences
OSI Pharmaceuticals
Kadmon Pharmaceuticals
Samyang Biopharm
Mitsubishi Pharma
Kaken Pharmaceutical
Selecta Biosciences
Par Pharmaceutical
Cerulean Pharma
Navidea Biopharmaceuticals
Lummy
End of Summary
Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL NANO-DRUG INDUSTRY
2.1 Summary about Nano-drug Industry
2.2 Nano-drug Market Trends
2.2.1 Nano-drug Production & Consumption Trends
2.2.2 Nano-drug Demand Structure Trends
2.3 Nano-drug Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Liposomes
4.2.2 Polymeric Micelles
4.2.3 Solid lipid Nanoparticles
4.2.4 Microemulsion and Nanoemulsion
4.2.5 Nanosuspension
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Cancer and Tumors
4.3.2 Autoimmune Disorders
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Liposomes
5.2.2 Polymeric Micelles
5.2.3 Solid lipid Nanoparticles
5.2.4 Microemulsion and Nanoemulsion
5.2.5 Nanosuspension
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Cancer and Tumors
5.3.2 Autoimmune Disorders
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Liposomes
6.2.2 Polymeric Micelles
6.2.3 Solid lipid Nanoparticles
6.2.4 Microemulsion and Nanoemulsion
6.2.5 Nanosuspension
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Cancer and Tumors
6.3.2 Autoimmune Disorders
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Liposomes
7.2.2 Polymeric Micelles
7.2.3 Solid lipid Nanoparticles
7.2.4 Microemulsion and Nanoemulsion
7.2.5 Nanosuspension
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Cancer and Tumors
7.3.2 Autoimmune Disorders
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Liposomes
8.2.2 Polymeric Micelles
8.2.3 Solid lipid Nanoparticles
8.2.4 Microemulsion and Nanoemulsion
8.2.5 Nanosuspension
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Cancer and Tumors
8.3.2 Autoimmune Disorders
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Liposomes
9.2.2 Polymeric Micelles
9.2.3 Solid lipid Nanoparticles
9.2.4 Microemulsion and Nanoemulsion
9.2.5 Nanosuspension
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Cancer and Tumors
9.3.2 Autoimmune Disorders
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Merck
10.1.2 Pfizer
10.1.3 Novartis
10.1.4 Abbott
10.1.5 GlaxoSmithKline
10.1.6 Roche
10.1.7 Sanofi
10.1.8 Eli Lilly
10.1.9 Astrazeneca
10.1.10 Johnson & Johnson
10.1.11 Celgene
10.1.12 Novavax
10.1.13 Stryker
10.1.14 Gilead Sciences
10.1.15 OSI Pharmaceuticals
10.1.16 Kadmon Pharmaceuticals
10.1.17 Samyang Biopharm
10.1.18 Mitsubishi Pharma
10.1.19 Kaken Pharmaceutical
10.1.20 Selecta Biosciences
10.1.21 Par Pharmaceutical
10.1.22 Cerulean Pharma
10.1.23 Navidea Biopharmaceuticals
10.1.24 Lummy
10.2 Nano-drug Sales Date of Major Players (2017-2020e)
10.2.1 Merck
10.2.2 Pfizer
10.2.3 Novartis
10.2.4 Abbott
10.2.5 GlaxoSmithKline
10.2.6 Roche
10.2.7 Sanofi
10.2.8 Eli Lilly
10.2.9 Astrazeneca
10.2.10 Johnson & Johnson
10.2.11 Celgene
10.2.12 Novavax
10.2.13 Stryker
10.2.14 Gilead Sciences
10.2.15 OSI Pharmaceuticals
10.2.16 Kadmon Pharmaceuticals
10.2.17 Samyang Biopharm
10.2.18 Mitsubishi Pharma
10.2.19 Kaken Pharmaceutical
10.2.20 Selecta Biosciences
10.2.21 Par Pharmaceutical
10.2.22 Cerulean Pharma
10.2.23 Navidea Biopharmaceuticals
10.2.24 Lummy
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
List of Tables and Figures
List of Table
Table Nano-drug Product Type Overview
Table Nano-drug Product Type Market Share List
Table Nano-drug Product Type of Major Players
Table Brief Introduction of Merck
Table Brief Introduction of Pfizer
Table Brief Introduction of Novartis
Table Brief Introduction of Abbott
Table Brief Introduction of GlaxoSmithKline
Table Brief Introduction of Roche
Table Brief Introduction of Sanofi
Table Brief Introduction of Eli Lilly
Table Brief Introduction of Astrazeneca
Table Brief Introduction of Johnson & Johnson
Table Brief Introduction of Celgene
Table Brief Introduction of Novavax
Table Brief Introduction of Stryker
Table Brief Introduction of Gilead Sciences
Table Brief Introduction of OSI Pharmaceuticals
Table Brief Introduction of Kadmon Pharmaceuticals
Table Brief Introduction of Samyang Biopharm
Table Brief Introduction of Mitsubishi Pharma
Table Brief Introduction of Kaken Pharmaceutical
Table Brief Introduction of Selecta Biosciences
Table Brief Introduction of Par Pharmaceutical
Table Brief Introduction of Cerulean Pharma
Table Brief Introduction of Navidea Biopharmaceuticals
Table Brief Introduction of Lummy
Table Products & Services of Merck
Table Products & Services of Pfizer
Table Products & Services of Novartis
Table Products & Services of Abbott
Table Products & Services of GlaxoSmithKline
Table Products & Services of Roche
Table Products & Services of Sanofi
Table Products & Services of Eli Lilly
Table Products & Services of Astrazeneca
Table Products & Services of Johnson & Johnson
Table Products & Services of Celgene
Table Products & Services of Novavax
Table Products & Services of Stryker
Table Products & Services of Gilead Sciences
Table Products & Services of OSI Pharmaceuticals
Table Products & Services of Kadmon Pharmaceuticals
Table Products & Services of Samyang Biopharm
Table Products & Services of Mitsubishi Pharma
Table Products & Services of Kaken Pharmaceutical
Table Products & Services of Selecta Biosciences
Table Products & Services of Par Pharmaceutical
Table Products & Services of Cerulean Pharma
Table Products & Services of Navidea Biopharmaceuticals
Table Products & Services of Lummy
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Nano-drug Market Forecast (Million USD) by Region 2021f-2026f
Table Global Nano-drug Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Nano-drug Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Nano-drug Market Forecast (Million USD) Share by Demand 2021f-2026f
List of Figure
Figure Global Nano-drug Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Nano-drug Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Nano-drug Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Nano-drug Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Nano-drug Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Nano-drug Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Nano-drug Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Liposomes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Polymeric Micelles Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Solid lipid Nanoparticles Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Microemulsion and Nanoemulsion Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Nanosuspension Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Cancer and Tumors Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Autoimmune Disorders Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Liposomes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Polymeric Micelles Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Solid lipid Nanoparticles Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Microemulsion and Nanoemulsion Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Nanosuspension Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Cancer and Tumors Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Autoimmune Disorders Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Liposomes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Polymeric Micelles Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Solid lipid Nanoparticles Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Microemulsion and Nanoemulsion Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Nanosuspension Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Cancer and Tumors Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Autoimmune Disorders Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Liposomes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Polymeric Micelles Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Solid lipid Nanoparticles Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Microemulsion and Nanoemulsion Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Nanosuspension Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Cancer and Tumors Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Autoimmune Disorders Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Liposomes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Polymeric Micelles Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Solid lipid Nanoparticles Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Microemulsion and Nanoemulsion Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Nanosuspension Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Cancer and Tumors Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Autoimmune Disorders Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Liposomes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Polymeric Micelles Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Solid lipid Nanoparticles Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Microemulsion and Nanoemulsion Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Nanosuspension Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Cancer and Tumors Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Autoimmune Disorders Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Nano-drug Sales Revenue (Million USD) of Merck 2017-2020e
Figure Nano-drug Sales Revenue (Million USD) of Pfizer 2017-2020e
Figure Nano-drug Sales Revenue (Million USD) of Novartis 2017-2020e
Figure Nano-drug Sales Revenue (Million USD) of Abbott 2017-2020e
Figure Nano-drug Sales Revenue (Million USD) of GlaxoSmithKline 2017-2020e
Figure Nano-drug Sales Revenue (Million USD) of Roche 2017-2020e
Figure Nano-drug Sales Revenue (Million USD) of Sanofi 2017-2020e
Figure Nano-drug Sales Revenue (Million USD) of Eli Lilly 2017-2020e
Figure Nano-drug Sales Revenue (Million USD) of Astrazeneca 2017-2020e
Figure Nano-drug Sales Revenue (Million USD) of Johnson & Johnson 2017-2020e
Figure Nano-drug Sales Revenue (Million USD) of Celgene 2017-2020e
Figure Nano-drug Sales Revenue (Million USD) of Novavax 2017-2020e
Figure Nano-drug Sales Revenue (Million USD) of Stryker 2017-2020e
Figure Nano-drug Sales Revenue (Million USD) of Gilead Sciences 2017-2020e
Figure Nano-drug Sales Revenue (Million USD) of OSI Pharmaceuticals 2017-2020e
Figure Nano-drug Sales Revenue (Million USD) of Kadmon Pharmaceuticals 2017-2020e
Figure Nano-drug Sales Revenue (Million USD) of Samyang Biopharm 2017-2020e
Figure Sales Revenue (Million USD) of Mitsubishi Pharma 2017-2020e
Figure Sales Revenue (Million USD) of Kaken Pharmaceutical 2017-2020e
Figure Sales Revenue (Million USD) of Selecta Biosciences 2017-2020e
Figure Sales Revenue (Million USD) of Par Pharmaceutical 2017-2020e
Figure Sales Revenue (Million USD) of Cerulean Pharma 2017-2020e
Figure Sales Revenue (Million USD) of Navidea Biopharmaceuticals 2017-2020e
Figure Sales Revenue (Million USD) of Lummy 2017-2020e